This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Nateglinide

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221031

Version

7

Spl Product Data Elements

Nateglinide Nateglinide NATEGLINIDE NATEGLINIDE ANHYDROUS CITRIC ACID SILICON DIOXIDE STARCH, CORN CROSPOVIDONE HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYSORBATE 80 POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE TALC TITANIUM DIOXIDE WHITE TO OFF-WHITE ROUND 721 Nateglinide Nateglinide NATEGLINIDE NATEGLINIDE ANHYDROUS CITRIC ACID CROSPOVIDONE FERRIC OXIDE RED FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 POVIDONE SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE LIGHT ORANGE TO ORANGE OVAL 722

Application Number

ANDA205248

Brand Name

Nateglinide

Generic Name

Nateglinide

Product Ndc

70771-1015

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1015-9 in bottle of 90 tablets Nateglinide Tablets USP, 60 mg Rx only 90 tablets NDC 70771-1016-9 in bottle of 90 tablets Nateglinide Tablets USP, 120 mg Rx only 90 tablets nateglinide tabs 60 mg nateglinide tabs 120 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.